Cable Hill Partners, LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 126 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cable Hill Partners, LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$22,000
+10.0%
6,000
+20.0%
0.01%
-12.5%
Q4 2018$20,000
-28.6%
5,0000.0%0.01%
-27.3%
Q3 2018$28,000
+600.0%
5,000
+400.0%
0.01%
+450.0%
Q2 2018$4,000
-20.0%
1,0000.0%0.00%0.0%
Q1 2018$5,0000.0%1,0000.0%0.00%0.0%
Q4 2017$5,000
-37.5%
1,000
-20.0%
0.00%
-50.0%
Q3 2017$8,000
-42.9%
1,250
-28.6%
0.00%
-50.0%
Q2 2017$14,000
+180.0%
1,750
+133.3%
0.01%
+166.7%
Q1 2017$5,0000.0%7500.0%0.00%
+50.0%
Q4 2016$5,000
-28.6%
7500.0%0.00%
-60.0%
Q3 2016$7,000
-12.5%
7500.0%0.01%
-16.7%
Q2 2016$8,000
+14.3%
7500.0%0.01%
+20.0%
Q1 2016$7,000
+16.7%
7500.0%0.01%
+25.0%
Q4 2015$6,000
+20.0%
7500.0%0.00%0.0%
Q3 2015$5,000
-28.6%
7500.0%0.00%
-20.0%
Q2 2015$7,000
+16.7%
7500.0%0.01%0.0%
Q1 2015$6,000
-14.3%
7500.0%0.01%
-28.6%
Q4 2014$7,0007500.01%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Triatomic Management LP 235,000$405,0000.23%
Green Alpha Advisors, LLC 147,380$254,0000.22%
Financial Advocates Investment Management 14,161$628,0000.05%
Virtus ETF Advisers LLC 72,540$125,0000.05%
Cedar Brook Financial Partners, LLC 88,750$153,0940.05%
Rafferty Asset Management, LLC 2,363,189$4,077,0000.04%
Hennion & Walsh Asset Management, Inc. 352,721$608,0000.04%
CAXTON ASSOCIATES LP 130,728$226,0000.03%
Keystone Financial Group 74,058$128,0000.03%
Virtu Financial LLC 130,829$226,0000.02%
View complete list of INOVIO PHARMACEUTICALS INC shareholders